Health
Glucosidase inhibitors are promising as new therapeutic agents for SARS-CoV-2 – Eminetra
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory…
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture at least one-hundredth of the required concentration. It reports that it has the ability to do so because of its cytotoxic effects.
As the pandemic of coronavirus disease 2019 (COVID-19) progresses, there is an urgent need for new antiviral agents that are effective against SARS-CoV-2,…
-
Noosa News18 hours agoResilience features in Sunshine Coast Open House
-
Noosa News13 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General11 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business14 hours agoBell Potter names the best ASX shares to buy in October